Fineotex Chemical Limited — Investor Meet, 26-05-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Fineotex Chemical has announced a board meeting to discuss the financial results for the quarter and half-year.

Fineotex reported FY25 revenue of Rs. 558 Cr with stable gross margins at 38.57%. EBITDA was Rs. 127 Cr, with margins down 222 bps to 23.85%, impacted by CAPEX and brand investments in water treatment and oil & gas. PAT stood at Rs. 109 Cr (20.48% margin) with exports contributing 22%. Textile chemicals grew with 25 new customers and 15 product launches in Q4. FMCG and hygiene saw temporary softness due to input costs but are expected to rebound. Water treatment and oil & gas segments showed strong volume and order pipeline growth, aided by global expansion and expos. A 15,000 MT greenfield plant is on track for Q2 FY26 to meet rising demand and ESG goals. The new biotech mosquito solution “AquaStrike Premium” targets global public health markets. Management remains confident despite geopolitical order delays, focusing on innovation, diversification, and operational excellence. Investor sentiment is positive on Fineotex’s expanding portfolio and global growth prospects.